Evaluation of Meningitis/Encephalitis (ME) Panel in the Detection of Infectious Organisms in CSF of Children by Scott, Alyssa & Villalobos, Tibisay, MD
Lehigh Valley Health Network
LVHN Scholarly Works
Research Scholars Poster Presentation
Evaluation of Meningitis/Encephalitis (ME) Panel





Lehigh Valley Health Network, tibisay.villalobos@lvhn.org
Follow this and additional works at: http://scholarlyworks.lvhn.org/research-scholars-posters
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Scott, A., Villalobos-Fry, T., (2017, July, 31) Evaluation of Meningitis/Encephalitis (ME) Panel in the Detection of Infectious Organisms in
CSF of Children. Poster presented at LVHN Research Scholar Program Poster Session, Lehigh Valley Health Network, Allentown, PA.
© 2017 Lehigh Valley Health Network
Lehigh Valley Health Network, Allentown, Pennsylvania
Evaluation of Meningitis/Encephalitis (ME) Panel in the Detection of Infectious Organisms in CSF 
of Children
• The faster turnaround time of ME panel compared to 
traditional culture is valuable in making earlier 
decisions about appropriate antimicrobial therapy
• Negative ME panel results for HSV allow for earlier 
discontinuation of empiric acyclovir therapy (<24 hrs)
• Future studies are needed to further look into the 






















Analyzed collected data; used two-sample t-tests for analysis 
of turnaround time, length of hospital stay, and 
antimicrobial duration 
Collected the following data from EPIC™: demographic 
information; admission and discharge dates; ME panel and 
culture results; time of sample collection and results; and 
antimicrobial duration
Retrospectively reviewed all FilmArray™ ME panels results 
from February 1, 2016 to May 31, 2017 for patients <18 
years of age
Figure 2. Viruses identified by ME panel. 
132 patients with ME panel 
results






107 (81%) patients w/ 
negative ME panel
OBJECTIVES
• The aim of this study is to evaluate the ME panel in children 
admitted to the Lehigh Valley Children’s Hospital by:
• Comparing the ME Panel results to traditional bacterial 
culture
• Analyzing clinical impact by measuring test turnaround 
time, length of hospital stay, and antimicrobial duration
• Central nervous system (CNS) infections are a common 
reason for admission of infants and children to the hospital 
and can lead to significant morbidity and mortality1
• Traditional diagnostic tests, such as bacterial culture, are 
limited in their sensitivity and turnaround time2,3
• The Biofire FilmArray™ Meningitis/Encephalitis (ME) Panel is 
a multiplex PCR panel that detects 14 bacteria, viruses, and 
yeasts in cerebrospinal fluid (CSF)
• This ME panel was approved by the FDA in October 2015, 
and was  implemented at LVHN in February 2016
• This new molecular test may be of clinical value due to its 




Alyssa Scott and Tibisay Villalobos-Fry,MD,FAAP
Figure 1. Overview of ME panel results. All patients with 
a positive ME panel were <2 years of age. 
Table 1 Comparison of turnaround time for ME panel and CSF 
culture





ME panel 132 7.2* (2.5-46.6)
CSF culture 131 28.4* (13.1-84.1)





Avg. duration of acyclovir 
(days)
HSV detected 2 20.5
HSV not detected 36 0.89
Table 2 Length of hospital stay for patients with positive and 
negative ME panels
ME panel result




Bacteria detected 19 (7-26)
Virus detected * 3.1** (1-10)
Negative 7.4** (0-132)
*HSV excluded from calculations
**significant difference between values (P < .05)
*significant difference between values (P < .05)





Avg. max duration of 
antimicrobials (days)
Bacteria detected 3 21
Virus detected* 20 1.6**
Negative ME panel 107 3.8**
*HSV excluded from calculations
**significant difference between values (P < .05)
